SavedAdd your journal

Journals / European Journal of Rheumatology / 2014 / Cilt: 1 - Sayı: 2

Yeni anlayışlarla eski bir hastalık: Gutun teşhis ve tedavisinde güncelleme

An old disease with new insights: Update on diagnosis and treatment of gout

Berivan BİTİK
M Akif ÖZTÜRK
Pages
72–77
Publication Date
2022-11-04
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This clinical review aims to summarize the diagnostic process and management of acute and chronic gout

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Gout is an acute and chronic inflammatory disorder associated with high morbidity and impaired quality of life.
📊
Key Findings & Data:There has been a substantial increase in the prevalence and incidence of gout in recent years.
💡
Conclusion & Impact:This clinical review aims to summarize the diagnostic process and management of acute and chronic gout
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Gout is an acute and chronic inflammatory disorder associated with high morbidity and impaired quality of life. There has been a substantial increase in the prevalence and incidence of gout in recent years. Novel diagnostic and therapeutic options have provided new insights into the pathogenesis and management of hyperuricemia and gout in the last decade. This clinical review aims to summarize the diagnostic process and management of acute and chronic gout

Özet

Gut, yüksek morbidite ve yaşam kalitesinde bozulma ile ilişkili akut ve kronik inflamatuvar bir hastalıktır. Son yıllarda, gut prevalansı ve insidansında önemli bir artış vardır. Son dekatta, yeni tanı ve tedavi seçenekleri, hiperürisemi ve gutun patogenezi ve tedavisi hakkında yeni anlayışlar sağlamıştır. Bu klinik derlemenin amacı akut ve kronik gutun tanı yöntemlerini ve tedavisini özetlemektir.

🔖

Cite This Article

BİTİK, B., ÖZTÜRK, M. A. (2022). Yeni anlayışlarla eski bir hastalık: Gutun teşhis ve tedavisinde güncelleme. European Journal of Rheumatology, Cilt: 1 - Sayı: 2, 72–77. https://ajindex.com/articles/650448

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (3)

  1. Annemans L, Spaepen E, Gaskin M, Bonnemaire M, Malier V, Gilbert T, et al. Gout in the UK and Germany: prevalence, comorbidities and man- agement in general practice 2000-2005. Ann Rheum Dis 2008; 67: 960-6. [CrossRef] Singh JA, Strand V. Gout is associated with more comorbidities, poorer health-related quality of life and higher healthcare utilisation in US veter- ans. Ann Rheum Dis 2008; 67: 1310-6. [CrossRef] Arromdee E, Michet CJ, Crowson CS, O'Fallon WM, Gabriel SE. Epidemiology of gout: is the incidence rising? J Rheumatol 2002; 29: 2403-6.
  2. Smith E, Hoy D, Cross M, Merriman TR, Vos T, Buchbinder R, et al. The global burden of gout: estimates from the Global Burden of Disease 2010 study. Ann Rheum Dis 2014. [CrossRef] Wallace KL, Riedel AA, Joseph-Ridge N, Wort- mann R. Increasing prevalence of gout and hy- peruricemia over 10 years among older adults in a managed care population. The Journal of rheumatology. 2004; 31: 1582-7.
  3. Birlik M, Gurler O, Akar S, Sari I, Onen F, Akkoc N. The prevalence of gout in an urban area of Izmir, Turkey: a population-based epidemiological study. Int J Clin Pract 2014; 68: 775-82. [CrossRef] Cakir N, Pamuk ON, Dervis E, Imeryuz N, Uslu H, Benian Ö, et al. The prevalences of some rheu- matic diseases in western Turkey: Havsa study. Rheumatol Int 2012; 32: 895-908. [CrossRef] Duskin-Bitan H, Cohen E, Goldberg E, Shochat T, Levi A, Garty M, et al. The degree of asymp- tomatic hyperuricemia and the risk of gout. A retrospective analysis of a large cohort. Clin Rheumatol 2014; 33: 549-53. [CrossRef] Choi HK, Mount DB, Reginato AM, American College of P, American Physiological S. Patho- genesis of gout. Annals of internal medicine. 2005; 143: 499-516. [CrossRef] Campion EW, Glynn RJ, DeLabry LO. Asymp- tomatic hyperuricemia. Risks and consequenc- es in the Normative Aging Study. Am J Med 1987; 82: 421-6. [CrossRef] Malawista SE, Duff GW, Atkins E, Cheung HS, Mc- Carty DJ. Crystal-induced endogenous pyrogen production. A further look at gouty inflammation. Arthritis Rheum 1985; 28: 1039-46. [CrossRef] Guerne PA, Terkeltaub R, Zuraw B, Lotz M. In- flammatory microcrystals stimulate interleu- kin-6 production and secretion by human monocytes and synoviocytes. Arthritis Rheum 1989; 32:1443-52. [CrossRef] di Giovine FS, Malawista SE, Thornton E, Duff GW. Urate crystals stimulate production of tu- mor necrosis factor alpha from human blood monocytes and synovial cells. Cytokine mRNA and protein kinetics, and cellular distribution. J